Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Mild to Moderate Crohn's Disease
NCT03078803Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Mar 2017
- Primary completion
- Jun 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in Crohn's disease, sponsored by University of Alberta. Started Mar 2017; status: completed.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03078803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078803.